Despite numerous studies have reported how the tumor microenvironment (TME) influences the tumor response to ICIs, a deeper understanding of its role in regulating immune responses in HNSCC would be needed, as it could better predict the behavior of this tumor toward PD-L1/PD-1-targeted therapies [8]. This evidence concerns the gene PDCD1 and neoplasm.